Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Immunotec Inc. IMMTF


Primary Symbol: V.IMM

Consumer Defensive Packaged Foods
"Immunotec Inc develops, manufactures, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the United States, the Dominican Republic and Mexico."


TSXV:IMM - Post by User

Immunotec Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by locust1on Jul 10, 2000 9:14pm
276 Views
Post# 2179434

RE: AIDS: Africa greatest disaster since slavery

RE: AIDS: Africa greatest disaster since slaveryGood stuff ... but I think Biochem Pharma AIDS stuff (one of the world's if not the world's largest supplier for AIDS treatment) is losing its effacacy against the mutant HIV strains. IMM has the AIDS therapy for treating both original & mutant HIV strains. However, IMM has not yet begun their clinical testing yet ... should be receiving IF7 (AIDS treatment) results this month. Hopefully will begin clinical testing beginning of next year. Another demonstration of the needs for IF7.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested